
Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
[ad_1] Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. [ad_2] Source…
[ad_1] Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. [ad_2] Source…
[ad_1] Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20% in a…